| The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets JW Nicol, GA Helt, SG Blanchard Jr, A Raja, AE Loraine Bioinformatics 25 (20), 2730-2731, 2009 | 715 | 2009 |
| PorthoMCL: parallel orthology prediction using MCL for the realm of massive genome availability E Tabari, Z Su Big Data Analytics 2, 1-5, 2017 | 38 | 2017 |
| Towards a map of cis-regulatory sequences in the human genome M Niu, E Tabari, P Ni, Z Su Nucleic acids research 46 (11), 5395-5409, 2018 | 21 | 2018 |
| De novo prediction of cis-regulatory elements and modules through integrative analysis of a large number of ChIP datasets M Niu, ES Tabari, Z Su BMC genomics 15 (1), 1047, 2014 | 14 | 2014 |
| A new algorithm for generation of different types of RNA E Seyedi-Tabari, H Ahrabian, A Nowzari-Dalini International Journal of Computer Mathematics 87 (6), 1197-1207, 2010 | 11 | 2010 |
| Molecular characteristics and disease burden metrics determined by next-generation sequencing on circulating tumor DNA correlate with progression free survival in previously … E Tabari, AF Lovejoy, H Lin, CR Bolen, SL Saelee, JP Lefkowitz, DM Kurtz, ... Blood 134, 490, 2019 | 4 | 2019 |
| Changes in circulating tumor DNA levels are associated with treatment response and progression-free survival in relapse/refractory DLBCL subjects. AF Lovejoy, H Lin, E Tabari, SL Saelee, DM Kurtz, P Vitazka, ... Journal of Clinical Oncology 37 (15_suppl), 7546-7546, 2019 | 2 | 2019 |
| ArrayInitiative-a tool that simplifies creating custom Affymetrix CDFs CC Overall, DA Carr, ES Tabari, KJ Thompson, JW Weller BMC bioinformatics 12, 1-11, 2011 | 2 | 2011 |
| Detection of early molecular response (EMR) and minimal residual disease (MRD) in patients with diffuse large B-cell lymphoma (DLBCL) using a validated next generation … RP Stokowski, E Tabari, P Bogard, C Hacker, OK Kameneva, T Ji, L Teng, ... Blood 140 (Supplement 1), 9257-9258, 2022 | 1 | 2022 |
| Systems and methods for cell of origin determination from variant calling data D Kurtz, H Lin, A Lovejoy, K Luong, E Tabari US Patent App. 17/597,760, 2022 | 1 | 2022 |
| NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL E Tabari, AF Lovejoy, H Lin, CR Bolen, S Lor Saelee, JP Lefkowitz, ... Leukemia & Lymphoma 65 (5), 618-628, 2024 | | 2024 |
| Inference of gene expression using fragmentation patterns from targeted high-depth sequencing of cell-free DNA E Leff, A Tseng, V Cheung, E Tabari, K Walter, A Lovejoy, CHJ Lin Cancer Research 84 (6_Supplement), 6258-6258, 2024 | | 2024 |
| Noninvasive longitudinal monitoring of residual disease in chemotherapy-treated colorectal cancer patients AD Tang, R Gupte, V Cheung, T Qing, A Cauwels, E Leff, K Walter, ... Cancer Research 84 (6_Supplement), 4788-4788, 2024 | | 2024 |
| Identification of High-Risk Population in First-Line Follicular Lymphoma at Screening with a Next Generation Sequencing (NGS) Assay Using Plasma Circulating Tumor DNA (ctDNA … A Bottos, C Woestmann, CR Bolen, M Shin, P Bogard, E Tabari, ... Blood 142, 1629, 2023 | | 2023 |
| Antisense transcription and its roles in adaption to environmental stress inE. coli L Zhao, E Tabari, H Rong, X Dong, D Xue, Z Su | | 2023 |
| Genetically defined subtypes of DLBCL from targeted panel on plasma match previously described tumor tissue subtypes E Tabari, AF Lovejoy, H Lin, CR Bolen, SL Saelee, JP Lefkowitz, DM Kurtz, ... Presented at the 25th European Hematology Association (EHA) Congress-Virtual …, 2020 | | 2020 |
Ann LoraineUniversity of North Carolina at CharlotteVerified email at uncc.edu
